Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade · PMID 42321916
View analysis →A grade · PMID 42372741
View analysis →A grade · PMID 42382416
View analysis →A grade · PMID 42150584
View analysis →This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 76.2/100. Study design: 75.0; human relevance: 90.0; therapeutic relevance: 56.2; sample size: 60.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 76.2/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 36.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 76.1/100. Study design: 100.0; human relevance: 100.0; therapeutic relevance: 28.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 76.1/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 35.5; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 76.1/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 40.3; sample size: 90.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 76.0/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 10.0; sample size: 70.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 76.0/100. Study design: 100.0; human relevance: 100.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 76.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 60.0; sample size: 50.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 76.0/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 20.0; sample size: 50.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 76.0/100. Study design: 100.0; human relevance: 75.0; therapeutic relevance: 10.0; sample size: 90.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 76.0/100. Study design: 100.0; human relevance: 100.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.9/100. Study design: 95.0; human relevance: 75.0; therapeutic relevance: 32.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.9/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 42.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.9/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 92.0; sample size: 40.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.9/100. Study design: 95.0; human relevance: 75.0; therapeutic relevance: 32.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.8/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.7/100. Study design: 75.0; human relevance: 90.0; therapeutic relevance: 53.7; sample size: 60.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.7/100. Study design: 80.0; human relevance: 95.0; therapeutic relevance: 36.0; sample size: 70.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.7/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 58.3; sample size: 50.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.6/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 73.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
